(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REBOUND THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

REBOUND THERAPEUTICS

ST13

US500000087434973

Class

10

Filing

87434973

Registration

5638746

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

08/21/2024

Classification

Registered

Trademark type

Word

Nice classes

10

Filing date

05/03/2017

Registration date

12/25/2018

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/21/2024

Last transaction

08/21/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/27/2017

First use in commerce

04/27/2017

Drawing code

4

Owner type

03

Owner location

Irvine, CA

Examiner

CASE, LEIGH CAROLINE

Current location

Historical data usage

Holders and representatives

Holders

R. C. (pessoa física)

Representatives

Eva Tan Integra LifeSciences Corporation

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical devicescannulae and sheaths for minimally invasive surgical access to the brain; imaging systems for neurosurgery; soft tissue resection devices and fluid aspiration devices for use in neurosurgery

Publications

History of USPTO decisions and trademark events.

39 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/21/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/21/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/21/2024

E815

TEAS SECTION 8 & 15 RECEIVED

02/05/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/25/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/31/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/31/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/31/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/31/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/31/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/25/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/20/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/19/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/15/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/14/2018

EX2G

SOU EXTENSION 2 GRANTED

11/14/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/14/2018

EXT2

SOU EXTENSION 2 FILED

11/07/2018

IUAF

USE AMENDMENT FILED

11/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2018

EISU

TEAS STATEMENT OF USE RECEIVED

11/07/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/16/2018

EX1G

SOU EXTENSION 1 GRANTED

05/14/2018

EXT1

SOU EXTENSION 1 FILED

05/14/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/14/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/21/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/26/2017

PUBO

PUBLISHED FOR OPPOSITION

09/26/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/06/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

08/03/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/03/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

08/03/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/03/2017

DOCK

ASSIGNED TO EXAMINER

07/31/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/18/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/18/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/09/2017

NWAP

NEW APPLICATION ENTERED

05/06/2017

Continuous trademark protection

Get notified about every new filing that threatens REBOUND THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.